Promising new front-line treatments for advanced kidney cancer
In an interview with OncLive during the 2017 State of the Science [...]
Adjuvant pazopanib shows no benefit for locally-advanced kidney cancer
Results from the phase 3 PROTECT clinical trial, which compared [...]
European Society of Medical Oncology (ESMO) highlights from the IKCC
The International Kidney Cancer Coalition (IKCC) had a booth at [...]
Kidney cancer highlights from the European Society of Medical Oncology
The following is an interview with Dr Toni K. Choueiri, medical oncologist at [...]
New combination treatment shows promise in kidney cancer
Results from a phase I clinical trial with a combination [...]
Combination treatment with atezolizumab plus bevacizumab improves progression-free survival
Results from the IMmotion150 phase II clinical trial showed that [...]
Lenvatinib plus pembrolizumab combination shows promise in advanced kidney cancer
Interim results from Study 111, a phase Ib/II clinical trial [...]
Results from phase 2 CABOSUN trial of cabozantinib versus sunitinib for first-line treatment of advanced kidney cancer
Ipsen and Exelixis have announced updated results from the phase 2 [...]
A new drug to treat solid tumours
The following blog from Mesothelioma.net gives a good summary of [...]
Combining radiotherapy with immunotherapy – a review of past, present and future developments
New immunotherapy treatments are currently revolutionising the field of oncology [...]
